The new guideline underscores the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with ALD.
The American College of Gastroenterology (ACG) published a new clinical guideline highlighting the need to overcome barriers to alcohol use disorder (AUD) treatment and expand multidisciplinary care for patients with alcohol-associated liver disease (ALD).
“Healthcare burdens from AUD and ALD are significant in the United States and worldwide and are increasing in recent years. Providers in all clinical areas must be prepared to care for this growing population of patients,” wrote researchers in the American Journal of Gastroenterology.
While ALD often occurs in the setting of AUD, patients with ALD rarely receive treatment for AUD. Because of this, “strategies are needed to overcome barriers to AUD treatment in patients with ALD and to promote a multidisciplinary integrated care model with hepatology, addiction medicine providers, and social workers to comprehensively manage the dual pathologies of liver disease and of AUD,” stated investigators.
First author Loretta Jophlin, MD, PhD, of the Division of Gastroenterology, Hepatology and Nutrition at the University of Louisville Health in Kentucky, and colleagues developed the practice guideline by performing a Grading of Recommendations, Assessment, Development and Evaluation analysis of data based on a patient-intervention-comparison-outcome format.
The analysis resulted in 34 key concepts or statements and 21 recommendations, which include the following:
“With continued and increasing interest of researchers and funding organizations…there seems light at the end of the tunnel with a promising future to fill the knowledge gap in several unmet clinical needs in the field of ALD,” concluded Jophlin and colleagues.
“Policy aimed at alcohol use reduction, multidisciplinary care of the dual diagnoses of AUD and ALD, and refinement of LT algorithms for patients with severe AH are areas where research should be focused,” they added.
Source: Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: Alcohol-associated liver disease. Am J Gastroenterol. 2024;119:30-54. doi:10.14309/ajg.0000000000002572